Loading...
Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
The central importance of angiogenesis and our understanding of how new blood vessels are formed have led to the development of novel antiangiogenic therapies. Although the number of agents in development has grown exponentially, only one phase III trial in breast cancer has been completed. In that...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2004
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC400679/ https://ncbi.nlm.nih.gov/pubmed/15084233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr782 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|